Like many other diseases, Alzheimer's moves in stages. In this video, HealthMaker Bruce Miller, MD describes the current treatment phases based on active symptoms.
The FTA has not approved any therapies yet for the very early stages of Alzheimer's Disease, that we call Mild cognitive impairment. Once the disease is caused functional impairment, we treat with drugs that boost the cedocholine. We also now have FTA approval to treat the later stages with drugs that boost cedocholine we call them cholinesterase inhibitors and also drugs that block the gludomade receptor.
Bruce Miller, MD, is a professor of neurology at the University of California, San Francisco. He directs the UCSF dementia center where patients in the San Francisco Bay Area receive comprehensive clinical evaluations.
See All HealthMakers